Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib
BiotechTV - News
00:00
Outro
Brad thanks Richard and wraps up the follow‑up discussion on Corvus's data and next steps.
Play episode from 27:08
Transcript
